Stock listing
Noxopharm Ltd.
Selected listing: NOX · ASX · AUD · AU
Noxopharm Ltd. (ASX:NOX), Health Technology. Latest release Aug 31, 2026: Novel oligonucleotides data presented at Options Conference.
- Ticker
- ASX:NOX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- ASX
- Currency
- AUD
About Noxopharm Ltd.
The company focuses on developing innovative therapies for cancer treatment. Noxopharm aims to improve patient outcomes through its research and development efforts in the pharmaceutical sector.
Latest news from Noxopharm Ltd.
Novel oligonucleotides data presented at Options Conference
August 31, 2026
Appendix 4E - Preliminary Financial Report
August 28, 2026
New preclinical data supports immuno-oncology approach
August 25, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
July 21, 2026
SOF-SKN manufacturing begins to ensure clinical trial readi
June 8, 2026